Study shows Topamax may treat alcoholism

10/9/2007 | Forbes · Wall Street Journal (free content), The

The drug topiramate, a treatment for migraine and epilepsy sold as Topamax by a unit of Johnson & Johnson, may help alcoholics stay away from heavy drinking, researchers report. In a study of 371 male and female alcoholics, Topamax reduced the percentage of heavy-drinking days per week from 81.9% to 43.8%, compared with a placebo, which lowered the percentage from 82% to 51.8% in the patients over a 14-week period.

View Full Article in:

Forbes · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN